Doctor profile · Federal record
Dr. Amudha Pazhanisamy
Allergy & Immunology Physician (CMS: Allergy/Immunology) · Student in an Organized Health Care Education/Training Program · Pediatrics Physician · Cleveland, OH
- NPI 1285297952
- Accepts Medicare
- 7 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9500 Euclid Ave
Cleveland, OH 441952664
(216) 444-6933
Credentials & registration
- NPI registered
- April 2019 — 7 yrs on file
- Profile last updated
- September 23, 2024
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 207K00000X — NUCC code
- State license (1)
- Ohio #57.031058
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285297952. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$200
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Csl Behring | 1 | $124.87 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $75.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
51
Patients
0
Total drug cost
$13,380
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Montelukast Sodium | Generic | 22 | 0 | $342 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 18 | 0 | $8,278 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 11 | 0 | $4,760 |
Frequently asked questions
What is Dr. Amudha Pazhanisamy's medical specialty?
Dr. Amudha Pazhanisamy practices Allergy & Immunology Physician in Cleveland, OH.
Where does Dr. Amudha Pazhanisamy practice?
Dr. Amudha Pazhanisamy practices at 9500 Euclid Ave, Cleveland, OH 441952664. Office phone: 2164446933.
What is Dr. Amudha Pazhanisamy's NPI?
Dr. Amudha Pazhanisamy's National Provider Identifier (NPI) is 1285297952, issued by NPPES.
Does Dr. Amudha Pazhanisamy accept Medicare assignment?
Yes. Dr. Amudha Pazhanisamy accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.